• Study of pelabresib (DAK539) plus ruxolitinib versus placebo plus ruxolitinib in adult patients with myelofibrosis who are JAK‑inhibitor‑naive

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia France Germany Italy +3

  • Safety and Efficacy of VX-828, Deutivacaftor, and Tezacaftor in Adults with Cystic Fibrosis

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Belgium Czechia Denmark France Germany Ireland +5

  • Safety and efficacy of venetoclax, obinutuzumab and daratumumab in adult patients with relapsed chronic lymphocytic leukemia

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

  • Evaluating venetoclax with drug combination in relapsed/refractory T‑cell acute lymphoblastic leukemia patients

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia France Germany The Netherlands Spain

  • Celecoxib versus placebo for pain and quality of life in adult patients with chronic pancreatitis

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study of TYRA-300 in Adults with Low Grade Upper Tract Urothelial Carcinoma to Assess Efficacy and Safety

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria France Spain

  • Phase II Study of Intratumoral Hydrogen Peroxide (KRC-01) Combined with Radiotherapy for Locally Advanced Rectal Cancer

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Shortening treatment duration in adults with uncomplicated candidemia: caspofungin acetate versus saline and sodium lactate placebo

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Oxytocin Nasal Spray for Reducing Cravings and Preventing Relapse in Adults with Substance Use Disorder

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Metformin hydrochloride plus drug combination to reduce pain, inflammation and biological aging in patients with knee osteoarthritis

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

powered by